Actuate Therapeutics (ACTU) Income Statement: Revenue & Earnings

Actuate Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Actuate Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00
Operating Expenses
Research & Development	18.68	21.71	16.39
Selling, General & Administrative	6.48	3.27	3.82
Operating Expenses	25.16	24.97	20.21
Operating Income	-25.16	-24.97	-20.21
Other Income/Expense
Interest Income	0.22	0.35	0.03
Interest Expense	-0.02	0.04	-0.02
Other Income/Expense	-0.08	-0.08	0.04
Income
Income Before Tax	-27.29	-24.74	-20.16
Income Tax Expense	0.00	0.00	0.00
Net Income	-27.29	-24.74	-20.16
Net Income - Continuous Operations	-27.29	-24.74	-20.16
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-25.16	-24.70	-20.14
EBIT	-25.16	-24.70	-20.21
Depreciation & Amortization	2.14	0.00	0.00
Earnings Per Share
Basic EPS	-3.00	-1.00	-17.00
Diluted EPS	-3.00	-1.00	-17.00
Basic Shares Outstanding	8.37	19.11	1.21
Diluted Shares Outstanding	8.37	19.11	1.21